3-167695669-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_007217.4(PDCD10):c.322C>T(p.Arg108Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_007217.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDCD10 | NM_007217.4 | c.322C>T | p.Arg108Ter | stop_gained | 6/9 | ENST00000392750.7 | NP_009148.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDCD10 | ENST00000392750.7 | c.322C>T | p.Arg108Ter | stop_gained | 6/9 | 1 | NM_007217.4 | ENSP00000376506 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460304Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726576
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 08, 2021 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23801932, 27561926, 25354366, 28645800, 31111464, 33891857) - |
PDCD10-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 03, 2023 | The PDCD10 c.322C>T variant is predicted to result in premature protein termination (p.Arg108*). This variant has been reported to be causative for cerebral cavernous malformations (CCMs) (Riant et al. 2013. PubMed ID: 23801932; Canavati et al. 2019. PubMed ID: 31111464). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating that it's rare. Nonsense variant in PDCD10 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Cerebral cavernous malformation 3 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 25, 2023 | This sequence change creates a premature translational stop signal (p.Arg108*) in the PDCD10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PDCD10 are known to be pathogenic (PMID: 15543491, 18300272, 23801932). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with cerebral cavernous malformations (PMID: 23801932, 25354366). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 468330). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at